A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina
- 1 May 1989
- journal article
- clinical trial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (3) , 45-50
- https://doi.org/10.1016/0732-8893(89)90065-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- EnterobacteriaceaeThe Pharmaceutical Journal, 2014
- In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strainsAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsAntimicrobial Agents and Chemotherapy, 1988
- Enterohepatic circulation of NY-198, a new difluorinated quinolone, in ratsAntimicrobial Agents and Chemotherapy, 1988
- In vitro and in vivo activity of NY-198, a new difluorinated quinoloneAntimicrobial Agents and Chemotherapy, 1987
- The fluoroquinolones: pharmacology, clinical uses, and toxicities in humansAntimicrobial Agents and Chemotherapy, 1985
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985